Business Insider: DURECT Announces Patient Dosing in Phase 2a Proof-of-Concept Clinical Trial of Topical DUR-928 in Patients with Mild to Moderate Plaque Psoriasis DURECT Announces Patient Dosing in Phase 2a Proof-of-Concept Clinical Trial of Topical DUR-928 in Patients with Mild to Moderate Plaque Psoriasis If you have plaque psoriasis, the most common form of psoriasis, you know the thick, raised, patches of skin called plaques can be itchy and painful. With mild to moderate cases of plaque psoriasis, ... The FDA has approved the first topical novel therapy for psoriasis in 25 years, Roivant Sciences announced.

Understanding the Context

Tapinarof cream 1% (Vtama) received an indication for mild, moderate, and severe plaque ... Vtama is a nonsteroidal cream for plaque psoriasis. Plaque psoriasis is a condition where the immune system causes the skin to make too many new cells too quickly. These extra skin cells pile up on ...

Key Insights

Reader's DigestHome Remedies for Eczema and Psoriasis ReliefSave money on expensive skin care treatments and try these homemade remedies first. Plaque psoriasis is a skin disease that causes raised ... Psoriasis is a chronic autoimmune condition that speeds up the skin cell cycle, leading to inflammation, scaling, and visible lesions. There are five main types of psoriasis, including Plaque ... The American Journal of Managed Care: Clinical Characteristics, Outcomes of Patients With Plaque Psoriasis on Tapinarof Cream